Literature DB >> 1777747

Platelet procoagulant activity: physiological significance and mechanisms of exposure.

E M Bevers1, P Comfurius, R F Zwaal.   

Abstract

This review describes an important function of blood platelets in the hemostatic process: the formation of a procoagulant surface. Two essential steps of the coagulation cascade, the formation of factor Xa and the formation of thrombin, require a catalytic surface on which the enzyme complexes can be assembled. This catalytic surface is provided by the phospholipids of the platelet plasma membrane. However, in the quiescent platelet, the negatively charged phospholipids which are essential to the catalytic properties of the surface, are located in the cytoplasmic leaflet of the membrane. Dependent on the activator, the normal asymmetric distribution of phospholipids is lost, resulting in the formation of a procoagulant surface. Although platelets are primarily predestined to exhibit this function, certain pathological conditions can lead to exposure of a procoagulant surface in other cells as well. Current views to explain the mechanisms of exposure of a procoagulant surface include the role of the cytoskeleton, the formation of microvesicles from the plasma membrane as well as the contribution of a membrane protein, which actively transports specific phospholipids from the outer-to inner leaflet of the membrane bilayer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777747     DOI: 10.1016/0268-960x(91)90031-7

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  30 in total

1.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Molecular imaging of platelet activation in thrombus.

Authors:  François Rouzet; Laure Sarda-Mantel; Jean-Baptiste Michel; Dominique Le Guludec
Journal:  J Nucl Cardiol       Date:  2009-02-18       Impact factor: 5.952

Review 3.  Infusible platelet membrane as a platelet substitute for transfusion: an overview.

Authors:  Saleh Nasiri
Journal:  Blood Transfus       Date:  2013-05-14       Impact factor: 3.443

4.  Report of the First French Anticardiolipin Antibodies Standardization Workshop.

Authors:  N Abuaf; O Meyer; S Laperche; N Saab; B Rajoely; A Deschamps; P Laroche; D Pierron; A M Rouquette
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

5.  Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

6.  Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects.

Authors:  Constance C F M J Baaten; Frauke Swieringa; Tomasz Misztal; Tom G Mastenbroek; Marion A H Feijge; Paul E Bock; Marjo M P C Donners; Peter W Collins; Renhao Li; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Blood Adv       Date:  2018-09-25

7.  Agonist-induced platelet procoagulant activity requires shear and a Rac1-dependent signaling mechanism.

Authors:  Michael Keegan Delaney; Junling Liu; Kyungho Kim; Bo Shen; Aleksandra Stojanovic-Terpo; Yi Zheng; Jaehyung Cho; Xiaoping Du
Journal:  Blood       Date:  2014-07-25       Impact factor: 22.113

Review 8.  Exposure of phosphatidylserine on the cell surface.

Authors:  S Nagata; J Suzuki; K Segawa; T Fujii
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

9.  Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.

Authors:  H Andersen; D L Greenberg; K Fujikawa; W Xu; D W Chung; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 10.  Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged.

Authors:  Armando Tripodi; Massimo Primignani; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2009-08-28       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.